Telomerase

Telomerase is a ribonucleoprotein complex composed of a catalytic reverse transcriptase subunit (TERT, telomerase reverse transcriptase) and an RNA template subunit (TERC/TR) that uses the RNA template to synthesize TTAGGG telomeric DNA repeats onto chromosome ends. By extending telomeres, telomerase directly counteracts the "end-replication problem" — the unavoidable loss of terminal DNA sequence with each round of DNA replication — that would otherwise drive progressive telomere shortening with cell division.

Why it matters in peptide research

Telomere length is often described as a "molecular clock" for cellular age. As cells divide, telomeres shorten; when they reach a critical minimal length, the cell enters permanent cell cycle arrest (replicative senescence) or undergoes apoptosis. Senescent cells accumulate in aged tissues and secrete a pro-inflammatory cocktail of cytokines and proteases — the senescence-associated secretory phenotype (SASP) — that degrades surrounding tissue and amplifies systemic inflammation.

Telomerase activity is high in stem cells, germ cells, and most cancers but is silenced or very low in the majority of somatic cells. This limitation is a fundamental driver of replicative aging in renewal tissues. The longevity research field has therefore pursued strategies to partially and transiently reactivate telomerase in somatic cells as a means to extend replicative lifespan, reduce SASP burden, and preserve tissue regenerative capacity.

The challenge is that telomerase is also a canonical cancer gene: most human cancers reactivate TERT as a critical step in achieving unlimited proliferative capacity. Any intervention targeting telomerase activation must therefore be carefully evaluated for cancer risk, particularly in individuals with pre-existing genetic instability or a history of malignancy. Current longevity research focuses on transient and moderate telomerase activation rather than constitutive overexpression.

Peptides that act on this

• Epitalon (Epithalon) — tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin (pineal gland extract); preclinical and limited human data suggest Epitalon stimulates telomerase activity and elongates telomeres in cultured cells and in vivo; proposed mechanism involves epigenetic changes at the TERT promoter.
• TA-65 — telomerase activator derived from astragalus; not a peptide but often compared to Epitalon in longevity discussions.

Common misconceptions

Telomerase activation is sometimes presented as straightforward "anti-aging." The reality is more nuanced: short telomeres in immune and stem cells are the functionally important targets, but constitutive or widespread TERT reactivation carries oncogenic risk. Additionally, telomere length is one of many hallmarks of aging; interventions that address only telomere attrition without affecting other aging pathways (epigenetic drift, protein aggregation, mitochondrial dysfunction) are unlikely to produce comprehensive rejuvenation.